Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder
Tourette Syndrome, Tic Disorders
About this trial
This is an interventional treatment trial for Tourette Syndrome focused on measuring Habit-reversal Therapy, Behavior Therapy, Supportive Therapy
Eligibility Criteria
Inclusion Criteria: Meets DSM-IV diagnostic criteria for Tourette syndrome or chronic tic disorder The primary reason for seeking treatment is Tourette syndrome and/or chronic tic disorder Either Tourette syndrome or chronic tic disorder is of more concern than any other simultaneous disease or disorder Score greater than 3 on the Clinical Global Impressions Severity Scale Score greater than 14 on the Yale Global Tic Severity Scale Unmedicated or on stable medication treatment for tics, obsessive compulsive disorder, attention deficit hyperactivity disorder, and/or depressive disorder for at least 6 weeks, and not planning to change medication for the duration of study participation Exclusion Criteria: Total tic score greater than 33 Score less than 80 on the Wechsler Test of Adult Reading DSM-IV diagnosis of alcohol or substance dependence within the 3 months prior to study enrollment Currently taking psychotropic medications for any psychiatric disorder (except for tics, obsessive compulsive disorder, attention deficit hyperactivity disorder, and/or depressive disorder) Any serious psychiatric disorder (e.g., bipolar disorder, psychosis) that requires immediate alternative treatment Previously treated with four or more sessions of habit-reversal therapy for tics
Sites / Locations
- Yale Child Study Center, Yale University
- OCD Clinic/Psychiatry, Massachusetts General Hospital
- University of Texas Health Sciences Center
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Active Comparator
1
2
Participants will receive supportive psychotherapy.
Participants will receive habit reversal therapy.